Last week, President Obama officially announced $100 million in funding for arguably the most ambitious neuroscience initiative ever proposed. The Brain Research through Advancing Innovative Neurotechnologies, or BRAIN, as the project is now called, aims to reconstruct the activity of every single neuron as they fire simultaneously in different brain circuits, or perhaps even whole brains.
Low-energy terahertz radiation could potentially enable doctors to see deep into tissues without the damaging effects of X-rays, or allow security guards to identify chemicals in a package without opening it. But it's been difficult for engineers to make powerful enough systems to accomplish these promising applications.
Analogic Corporation, enabling the world's medical imaging and aviation security technology, announced that it is showcasing, for the first time in the U.S., its BK Medical Flex Focus™ 500 ultrasound system, the SonixTablet with GPS needle guidance, and the SonixTouch Research systems together at the American Institute of Ultrasound in Medicine (AIUM) 2013 Annual Convention.
Workers in the Medical device industry earn, in general, higher salaries than their counterparts across American business, according figures recently released by the Federal Bureau of Labor & Statistics. The good news for medtech starts at the top, where executives and top line managers earn an annual mean salary of $139,620, about 21% higher than their counterparts in business who earn $114,850 on average.
Dementia’s financial impact on the U.S. economy in 2010 was around $109 billion, reported researchers in the New England Journal of Medicine on Wednesday. That figure largely consists of the costs of nursing-home care and home-based care, and it will likely double by 2040 as the population ages, according to the study.
St. Jude Medical was slapped with multiple lawsuits in California courts yesterday over its recalled Riata defibrillator lead, alleging that the heart wires were defective and led to injuries or death for more than 30 patients. The lawsuits generally accuse St. Jude of violating both state and federal requirements for reporting issues with medical devices...
The FDA put its highest-risk category on Johnson & Johnson subsidiary Animas Corp.'s insulin pump recall over concerns that the devices may cause patient harm or even death. Certain pumps were recalled over concerns that a "component" issue could trigger a false alarm or a sudden warning requiring that the patient rewind, load and prime the device.
Singapore-based Hoya Surgical Optics recalled 5 models of its intraocular lenses after receiving reports of higher-than expected rates of inflammation from doctors in several countries. Healthcare regulators in the U.K. and in Australia have both reported the recall, asking doctors to stop using the implants immediately.
CLEVELAND, April 5, 2013 /PRNewswire/ -- The first-in-human study of the NeuroBlate™ Thermal Therapy System finds that it appears to provide a new, safe and minimally invasive procedure for treating recurrent glioblastoma (GBM), a malignant type of brain tumor. The...
The FDA's Orthopaedic & Rehabilitation Devices Panel postponed today's meeting over scheduling conflicts that meant key players couldn't attend. The meeting was convened to discuss a possible reclassification of shortwave diathermy devices, which are used to therapeutically heat tissue with an electric current with applications in joint inflammation treatments and physiotherapy.
A federal appeals court says that a Johnson & Johnson heart stent does not infringe a patent held by a doctor and inventor, overturning a $482 million decision against the company.
Animas has identified a component issue affecting Animas(R) 2020 Infusion Insulin Pumps manufactured from March 1, 2012 to November 30, 2012. The component issue may trigger the pumps to sound a false alarm or warning related to one of the following...
MAKO Surgical Corp. (Nasdaq: MAKO) today announced that it has obtained an Order Granting Permanent Injunction enjoining Blue Belt Technologies, Inc. from engaging a former MAKO employee and requiring the destruction of all proprietary MAKO business information in Blue Belt's possession.
A technology being developed at the Department of Energy's Oak Ridge National Laboratory promises to provide clear images of the brains of children, the elderly, and people with Parkinson's and other diseases without the use of uncomfortable or intrusive restraints.
Swiss medical device maker Symetis released 30-day registry findings for its 2nd-generation transcatheter aortic valve implantation systems, touting high procedural success rates and minimal valve leakage. Results from the SAVI postmarket registry highlighted findings from the 1st 250 patients implanted with Symetis' Acurate TA TAVI system, which won European regulatory approval in September 2011.